BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3620027)

  • 1. [Lymph node histopathologic aspects in cutaneous lymphomas of the mycosis fungoides or Sézary syndrome type. Retrospective study of 98 biopsies].
    Wechsler J; Diebold J; Gerard-Marchant R
    Ann Pathol; 1987; 7(2):122-9. PubMed ID: 3620027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lymph node localization of epidermotropic T malignant lymphomas (mycosis fungoides and Sézary's syndrome)].
    Wechsler J; Diebold J; Gérard-Marchant R
    Bull Cancer; 1984; 71(2):89-99. PubMed ID: 6610451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
    Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical studies using monoclonal antibodies on lymph nodes from patients with mycosis fungoides and Sézary's syndrome.
    Willemze R; Scheffer E; Meijer CJ
    Am J Pathol; 1985 Jul; 120(1):46-54. PubMed ID: 3893151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mycosis fungoides and Sézary syndrome. A retrospective study of 60 patients with correlation between histologic classification and survival time].
    Hödl S
    Z Hautkr; 1986 Jul; 61(14):993-1013. PubMed ID: 3751216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non lymphoblastic T cell lymphomas with prevalent skin involvement different from mycosis fungoides or Sézary's syndrome. A retrospective study of 6 cases in Europe.
    Grob JJ; Horchowski N; Tubiana N; Gabriel B; Gastaut JA; Hassoun J; Jouve I; Carcassone Y; Bonerandi JJ
    Dermatologica; 1988; 177(2):82-97. PubMed ID: 3262542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies.
    Pai RK; Mullins FM; Kim YH; Kong CS
    Cancer; 2008 Oct; 114(5):323-32. PubMed ID: 18798522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome.
    Kim YH; Bishop K; Varghese A; Hoppe RT
    Arch Dermatol; 1995 Sep; 131(9):1003-8. PubMed ID: 7661601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic assessment of lymph nodes in mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma): clinical correlations and prognostic import of a new classification system.
    Sausville EA; Worsham GF; Matthews MJ; Makuch RW; Fischmann AB; Schechter GP; Gazdar AF; Bunn PA
    Hum Pathol; 1985 Nov; 16(11):1098-109. PubMed ID: 3876976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermatopathic lymphadenopathy. Comparison of cases associated and unassociated with mycosis fungoides.
    Burke JS; Colby TV
    Am J Surg Pathol; 1981 Jun; 5(4):343-52. PubMed ID: 7270782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node involvement by mycosis fungoides and Sézary syndrome mimicking angioimmunoblastic T-cell lymphoma.
    LeBlanc RE; Lefterova MI; Suarez CJ; Tavallaee M; Kim YH; Schrijver I; Kim J; Gratzinger D
    Hum Pathol; 2015 Sep; 46(9):1382-9. PubMed ID: 26193796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine-needle aspiration biopsy in the evaluation of lymphadenopathy associated with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome).
    Galindo LM; Garcia FU; Hanau CA; Lessin SR; Jhala N; Bigler RD; Vonderheid EC
    Am J Clin Pathol; 2000 Jun; 113(6):865-71. PubMed ID: 10874888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic significance of clonal T-cell receptor beta gene rearrangements in lymph nodes of patients with mycosis fungoides.
    Bakels V; Van Oostveen JW; Geerts ML; Gordijn RL; Walboomers JM; Scheffer E; Meijer CJ; Willemze R
    J Pathol; 1993 Jul; 170(3):249-55. PubMed ID: 8133398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycosis fungoides and the Sézary syndrome.
    Kim YH; Hoppe RT
    Semin Oncol; 1999 Jun; 26(3):276-89. PubMed ID: 10375085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of cutaneous T-cell lymphoma.
    Abel EA
    Dermatol Clin; 1985 Oct; 3(4):647-64. PubMed ID: 2878755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood and lymph node T lymphocytes in cutaneous T cell lymphoma: evaluation by light microscopy.
    Schechter GP; Bunn PA; Fischmann AB; Matthews MJ; Guccion J; Soehnlen F; Munson D; Minna JD
    Cancer Treat Rep; 1979 Apr; 63(4):571-4. PubMed ID: 312694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermatopathic lymphadenopathy and lymph node involvement in mycosis fungoides.
    Scheffer E; Meijer CJ; Van Vloten WA
    Cancer; 1980 Jan; 45(1):137-48. PubMed ID: 7350998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
    Kim YH; Liu HL; Mraz-Gernhard S; Varghese A; Hoppe RT
    Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome. Definition of three distinctive prognostic groups.
    Sausville EA; Eddy JL; Makuch RW; Fischmann AB; Schechter GP; Matthews M; Glatstein E; Ihde DC; Kaye F; Veach SR
    Ann Intern Med; 1988 Sep; 109(5):372-82. PubMed ID: 3408055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal Langerhans cells in mycosis fungoides and Sézary syndrome.
    Matejka M; Konrad K
    Wien Klin Wochenschr; 1983 Dec; 95(23):847-52. PubMed ID: 6670281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.